Sign in
What are the management issues for hepatitis C in dialysis patients?: natural history of hepatitis C in dialysis populations
Journal article   Peer reviewed

What are the management issues for hepatitis C in dialysis patients?: natural history of hepatitis C in dialysis populations

Andres F Carrion and Paul Martin
Seminars in dialysis, Vol.27(5), pp.446-448
2014-09
PMID: 25204876

Abstract

Simeprevir Hepatitis C - drug therapy Antiviral Agents - therapeutic use Liver Cirrhosis - complications Humans Liver Neoplasms - complications Kidney Transplantation Asymptomatic Diseases Renal Insufficiency, Chronic - complications Renal Insufficiency, Chronic - therapy Carcinoma, Hepatocellular - complications Sulfonamides - therapeutic use Heterocyclic Compounds, 3-Ring - therapeutic use Uridine Monophosphate - analogs & derivatives Hepatitis C - complications Sofosbuvir Renal Dialysis Uridine Monophosphate - therapeutic use

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics
1 Clinical & Life Sciences
1.125 Hepatitis
1.125.83 HCV
Web Of Science research areas
Urology & Nephrology
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details